News Focus
News Focus
icon url

exwannabe

06/23/25 2:22 PM

#772549 RE: eagle8 #772548

So this was, I think, the Trial in question.


So UCLA is located in Germany. OK

Now we do have the confusion with GBM vs colorectal to deal with., But as this entire thread suffers from H up A disease, that is OK also.
icon url

manibiotech

06/23/25 2:24 PM

#772550 RE: eagle8 #772548

Your link has absolutely nothing to do with colorectal cancer . 
icon url

skitahoe

06/23/25 4:31 PM

#772568 RE: eagle8 #772548

Trials that are temporarily unblinded are never reported on.  If the data is spectacular, they may recommend ending the trial early, and that would be reported. If the data was bad, they would recommend halting the trial for futility.   If they are satisfied with the data, then the trial just continues.
I don't believe that the company sees details, they just see the recommendation which normally is to continue. Peeks at the data rarely end the trial early for efficacy, but occasionally it will happen. 
Gary